Carregant...

Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome

Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Nephrol
Autors principals: Walsh, Patrick R., Johnson, Sally
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6660499/
https://ncbi.nlm.nih.gov/pubmed/30058046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-018-4025-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!